Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

5 Value Stocks In The Healthcare Sector

Author: Benzinga Insights | July 18, 2022 10:45am

What is a Value Stock?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

  1. eFFECTOR Therapeutics (NASDAQ:EFTR) - P/E: 1.81
  2. Quest Diagnostics (NYSE:DGX) - P/E: 9.05
  3. Ironwood Pharmaceuticals (NASDAQ:IRWD) - P/E: 3.68
  4. Global Cord Blood (NYSE:CO) - P/E: 4.13
  5. Fonar (NASDAQ:FONR) - P/E: 9.51

eFFECTOR Therapeutics saw a decrease in earnings per share from 0.44 in Q4 to $0.07 now. Quest Diagnostics saw a decrease in earnings per share from 3.33 in Q4 to $3.22 now. Most recently, the company reported a dividend yield of 1.95%, which has increased by 0.01% from last quarter's yield of 1.94%.

Ironwood Pharmaceuticals has reported Q1 earnings per share at $0.21, which has decreased by 22.22% compared to Q4, which was 0.27. Global Cord Blood's earnings per share for Q4 sits at $0.14, whereas in Q3, they were at 0.17. Fonar's earnings per share for Q3 sits at $0.32, whereas in Q2, they were at 0.57.

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

Posted In: CO DGX EFTR FONR IRWD